Innate Pharma (IPHA) Pension (2017 - 2025)

Innate Pharma (IPHA) has disclosed Pension for 8 consecutive years, with $2.9 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Pension rose 11.08% year-over-year to $2.9 million, compared with a TTM value of $2.9 million through Dec 2024, up 11.08%, and an annual FY2024 reading of $3.0 million, up 11.9% over the prior year.
  • Pension was $2.9 million for Q4 2024 at Innate Pharma, up from $2.6 million in the prior quarter.
  • Across five years, Pension topped out at $5.0 million in Q4 2020 and bottomed at $2.6 million in Q4 2022.
  • Average Pension over 5 years is $3.3 million, with a median of $2.9 million recorded in 2024.
  • The sharpest move saw Pension rose 19.66% in 2020, then tumbled 31.66% in 2021.
  • Year by year, Pension stood at $5.0 million in 2020, then plummeted by 31.66% to $3.4 million in 2021, then fell by 23.56% to $2.6 million in 2022, then rose by 0.95% to $2.6 million in 2023, then increased by 11.08% to $2.9 million in 2024.
  • Business Quant data shows Pension for IPHA at $2.9 million in Q4 2024, $2.6 million in Q4 2023, and $2.6 million in Q4 2022.